OrthoNetx’ unique product approach relies on four primary advantages over competing products:

1. Safer and less invasive — the GenerOs products take advantage of miniaturization and advanced engineering technology to provide products requiring less tissue disruption and scarring with use, and fewer overall steps to complete bone generation/repair. This strategy promotes faster healing, fewer risks and less expense for patients and payers.



2. Fully implantable for better cosmesis and function — GenerOs products are designed to minimize external scarring and achieve superior cosmetic results than competing products. GenerOs products preserve range of joint motion and result in quicker rehabilitation.



3. Risk management for company, doctor and patient — OrthoNetx employs proprietary information technology to assure the training and certification of its physician customers and the informed consent of patients relative to the use of its products. Further, OrthoNetx is dedicated to post-market surveillance and adverse event monitoring of its products that will provide regulatory economy, yet exceed current global regulatory requirements.



4. Patient and Physician Relationship Management — OrthoNetx’ proprietary information technology establishes continuous, permission-based communication links with its physicians and patients to continually understand and support customer need.

OrthoNetx’ current proprietary, patent-protected GenerOs products include:

• GenerOs ™ CF craniofacial bone generator



• GenerOs ™ EX limb lengthener



• GenerOs ™ DI dental implant distractor



• GenerOs ™ SB small bone generator